News

Chicago, Illinois July 8, 2025 – Cure CMT, a leading advocacy organization dedicated to finding treatments and cures for Charcot-Marie-Tooth disease, today announced a significant partnership with Tamarack Habilitation Technologies, Inc., a Minnesota-based leader in orthotic and prosthetic innovation. Through this collaboration, Tamarack has provided a generous investment to support Cure CMT's mission while making their advanced orthotic products directly accessible to CMT patients through Cure CMT's website platform. Charcot-Marie-Tooth disease affects approximately 1 in 2,500 people worldwide, causing progressive muscle…

A new clinical trial is offering hope for people with Charcot-Marie-Tooth (CMT) disease. Researchers tested a plasmid-based gene therapy designed to support nerve and muscle function. Unlike viral gene therapies, this treatment can be given multiple times without triggering an immune response—making it a promising option for chronic conditions like CMT. In a small Phase 1 trial in Seoul, South Korea, 12 participants with CMT type 1A received injections of the therapy over 104 days. The results? No serious side…

For people living with Charcot-Marie-Tooth (CMT) disease, something as simple as walking can be a daily challenge. Braces and surgery can restore mobility and independence but they’re often out of reach due to high costs. Your donations make these life-changing treatments possible. Why It Matters CMT is a progressive disease that weakens muscles and affects balance and mobility. Many patients need custom braces (AFOs) to walk safely or surgeries to correct painful foot deformities. These essential treatments aren’t always covered…